Whenever any two companies come together on a project, a contract will stipulate the terms of work involved. Before Big Pharma and biotech companies start working with CMOs, they should also formulate service agreements, as Raul Soikes, senior director of program management in R&D at Baxter International, recommended at Interphex this year. These agreements would outline the expectations of each party early in the working relationship to ensure efficiency and time savings, as Outsourcing-Pharma explains. Story